Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385686323> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4385686323 endingPage "160.18" @default.
- W4385686323 startingPage "160.18" @default.
- W4385686323 abstract "Abstract Lipid nanoparticles (LNP) are essential components of messenger RNA (mRNA) vaccines that have been a cornerstone of the COVID-19 public health response. These LNPs are used for cell entry and protection of the mRNA. Others have shown that the LNP of the BNT162b2 vaccine is able to augment the immune response against the vaccine target. However, it is unknown how this LNP stimulates innate immune cells such as monocytes that participate in the engagement of the adaptive immune response. We used a THP-1 monocyte reporter cell line for nuclear factor kappa B (NF-κB) and interferon regulatory factor (IRF) activation to understand if empty LNPs could stimulate innate cells in comparison with toll-like receptor (TLR) agonists. With this cell line, we show that the BNT162b2’s LNP is able to initiate activation of NF-κB, but not IRF in a dose-dependent manner. The NF-κB response was similar to that of low doses of R848, a TLR 7/8 agonist, as well as LPS, a TLR4 agonist. Next, we evaluated NF-kB activation in the absence of MyD88 or TRIF using knockout reporter cell lines. We demonstrate that NF-κB activation is reduced in both knockout cell lines. In comparison, LPS primarily stimulated NF-kB activation through MyD88, and R848 relies on both pathways. Our data show that LNPs can stimulate key innate immune cells through NF-kB pathways but not through IRF suggesting that this master regulator may participate in the immune activation induced by the current mRNA vaccine platform. Moreover, our data suggest that LNPs can use both MyD88 and TRIF signaling cascades to induce activation. Understanding the mechanisms behind the immunostimulatory capacity of LNPs can shed light on modulating these vaccine components to enhance vaccine design. Defense Health Program, HU00012120094" @default.
- W4385686323 created "2023-08-10" @default.
- W4385686323 creator A5009560249 @default.
- W4385686323 creator A5030861448 @default.
- W4385686323 creator A5042986748 @default.
- W4385686323 creator A5092793632 @default.
- W4385686323 date "2023-05-01" @default.
- W4385686323 modified "2023-09-23" @default.
- W4385686323 title "The BNT162b2 vaccine’s empty lipid nanoparticle is able to induce an NF-κB response" @default.
- W4385686323 doi "https://doi.org/10.4049/jimmunol.210.supp.160.18" @default.
- W4385686323 hasPublicationYear "2023" @default.
- W4385686323 type Work @default.
- W4385686323 citedByCount "0" @default.
- W4385686323 crossrefType "journal-article" @default.
- W4385686323 hasAuthorship W4385686323A5009560249 @default.
- W4385686323 hasAuthorship W4385686323A5030861448 @default.
- W4385686323 hasAuthorship W4385686323A5042986748 @default.
- W4385686323 hasAuthorship W4385686323A5092793632 @default.
- W4385686323 hasBestOaLocation W43856863231 @default.
- W4385686323 hasConcept C136449434 @default.
- W4385686323 hasConcept C185592680 @default.
- W4385686323 hasConcept C193419808 @default.
- W4385686323 hasConcept C203014093 @default.
- W4385686323 hasConcept C2776070231 @default.
- W4385686323 hasConcept C2776090121 @default.
- W4385686323 hasConcept C2776709828 @default.
- W4385686323 hasConcept C2777730290 @default.
- W4385686323 hasConcept C2779836521 @default.
- W4385686323 hasConcept C43929388 @default.
- W4385686323 hasConcept C62478195 @default.
- W4385686323 hasConcept C86803240 @default.
- W4385686323 hasConcept C8891405 @default.
- W4385686323 hasConcept C95444343 @default.
- W4385686323 hasConceptScore W4385686323C136449434 @default.
- W4385686323 hasConceptScore W4385686323C185592680 @default.
- W4385686323 hasConceptScore W4385686323C193419808 @default.
- W4385686323 hasConceptScore W4385686323C203014093 @default.
- W4385686323 hasConceptScore W4385686323C2776070231 @default.
- W4385686323 hasConceptScore W4385686323C2776090121 @default.
- W4385686323 hasConceptScore W4385686323C2776709828 @default.
- W4385686323 hasConceptScore W4385686323C2777730290 @default.
- W4385686323 hasConceptScore W4385686323C2779836521 @default.
- W4385686323 hasConceptScore W4385686323C43929388 @default.
- W4385686323 hasConceptScore W4385686323C62478195 @default.
- W4385686323 hasConceptScore W4385686323C86803240 @default.
- W4385686323 hasConceptScore W4385686323C8891405 @default.
- W4385686323 hasConceptScore W4385686323C95444343 @default.
- W4385686323 hasIssue "1_Supplement" @default.
- W4385686323 hasLocation W43856863231 @default.
- W4385686323 hasOpenAccess W4385686323 @default.
- W4385686323 hasPrimaryLocation W43856863231 @default.
- W4385686323 hasRelatedWork W1914689199 @default.
- W4385686323 hasRelatedWork W1967467892 @default.
- W4385686323 hasRelatedWork W1988327539 @default.
- W4385686323 hasRelatedWork W1992245975 @default.
- W4385686323 hasRelatedWork W2071860886 @default.
- W4385686323 hasRelatedWork W2086443859 @default.
- W4385686323 hasRelatedWork W2132137833 @default.
- W4385686323 hasRelatedWork W2572800298 @default.
- W4385686323 hasRelatedWork W320525602 @default.
- W4385686323 hasRelatedWork W4252340966 @default.
- W4385686323 hasVolume "210" @default.
- W4385686323 isParatext "false" @default.
- W4385686323 isRetracted "false" @default.
- W4385686323 workType "article" @default.